|
1
|
Emergence of multiply resistant pneumococci.
|
N Engl J Med
|
1978
|
8.32
|
|
2
|
Acute otitis media: management and surveillance in an era of pneumococcal resistance--a report from the Drug-resistant Streptococcus pneumoniae Therapeutic Working Group.
|
Pediatr Infect Dis J
|
1999
|
5.88
|
|
3
|
Mutations in 23S rRNA and ribosomal protein L4 account for resistance in pneumococcal strains selected in vitro by macrolide passage.
|
Antimicrob Agents Chemother
|
2000
|
4.31
|
|
4
|
Study of comparative antipneumococcal activities of penicillin G, RP 59500, erythromycin, sparfloxacin, ciprofloxacin, and vancomycin by using time-kill methodology.
|
Antimicrob Agents Chemother
|
1994
|
3.12
|
|
5
|
Two new mechanisms of macrolide resistance in clinical strains of Streptococcus pneumoniae from Eastern Europe and North America.
|
Antimicrob Agents Chemother
|
2000
|
3.00
|
|
6
|
Spread of drug-resistant Streptococcus pneumoniae in Asian countries: Asian Network for Surveillance of Resistant Pathogens (ANSORP) Study.
|
Clin Infect Dis
|
1999
|
2.74
|
|
7
|
Antimicrobial susceptibility testing of pneumococci. 2. Determination of optimal disc diffusion test for detection of penicillin G resistance.
|
J Antimicrob Chemother
|
1980
|
2.73
|
|
8
|
Comparative activities of the beta-lactamase inhibitors YTR 830, sodium clavulanate, and sulbactam combined with amoxicillin or ampicillin.
|
Antimicrob Agents Chemother
|
1984
|
2.71
|
|
9
|
Infection caused by vancomycin-resistant Streptococcus sanguis II.
|
Antimicrob Agents Chemother
|
1984
|
2.66
|
|
10
|
Susceptibilities of penicillin-susceptible and -resistant strains of Streptococcus pneumoniae to RP 59500, vancomycin, erythromycin, PD 131628, sparfloxacin, temafloxacin, win 57273, ofloxacin, and ciprofloxacin.
|
Antimicrob Agents Chemother
|
1992
|
2.64
|
|
11
|
Ligase chain reaction for detection of Neisseria gonorrhoeae in urogenital swabs.
|
J Clin Microbiol
|
1995
|
2.62
|
|
12
|
Comparative activities of the beta-lactamase inhibitors YTR 830, clavulanate, and sulbactam combined with ampicillin and broad-spectrum penicillins against defined beta-lactamase-producing aerobic gram-negative bacilli.
|
Antimicrob Agents Chemother
|
1986
|
2.48
|
|
13
|
Once-daily vs. continuous aminoglycoside dosing: efficacy and toxicity in animal and clinical studies of gentamicin, netilmicin, and tobramycin.
|
J Infect Dis
|
1983
|
2.41
|
|
14
|
Comparative activity of beta-lactamase inhibitors YTR 830, clavulanate, and sulbactam combined with beta-lactams against beta-lactamase-producing anaerobes.
|
Antimicrob Agents Chemother
|
1986
|
2.39
|
|
15
|
Antimicrobial susceptibility testing of pneumococci: determination of Kirby-Bauer breakpoints for penicillin G, erythromycin, clindamycin, tetracycline, chloramphenicol, and rifampin.
|
Antimicrob Agents Chemother
|
1979
|
2.32
|
|
16
|
Frequency and significance of isolation of Ureaplasma urealyticum and Mycoplasma hominis from cerebrospinal fluid and tracheal aspirate specimens from low birth weight infants.
|
J Pediatr
|
1994
|
2.25
|
|
17
|
Beta-lactamase production and susceptibilities to amoxicillin, amoxicillin-clavulanate, ticarcillin, ticarcillin-clavulanate, cefoxitin, imipenem, and metronidazole of 320 non-Bacteroides fragilis Bacteroides isolates and 129 fusobacteria from 28 U.S. centers.
|
Antimicrob Agents Chemother
|
1990
|
2.25
|
|
18
|
Activity of CP 99,219 compared with those of ciprofloxacin, grepafloxacin, metronidazole, cefoxitin, piperacillin, and piperacillin-tazobactam against 489 anaerobes.
|
Antimicrob Agents Chemother
|
1994
|
2.21
|
|
19
|
Resistance mechanisms of multiply resistant pneumococci: antibiotic degradation studies.
|
Antimicrob Agents Chemother
|
1979
|
2.17
|
|
20
|
Variation in erythromycin and clindamycin susceptibilities of Streptococcus pneumoniae by four test methods.
|
Antimicrob Agents Chemother
|
1997
|
2.17
|
|
21
|
Activity of CP99,219 compared with DU-6859a, ciprofloxacin, ofloxacin, levofloxacin, lomefloxacin, tosufloxacin, sparfloxacin and grepafloxacin against penicillin-susceptible and -resistant pneumococci.
|
J Antimicrob Chemother
|
1995
|
2.13
|
|
22
|
In vitro development of resistance to five quinolones and amoxicillin-clavulanate in Streptococcus pneumoniae.
|
Antimicrob Agents Chemother
|
1999
|
2.04
|
|
23
|
MIC and time-kill study of activities of DU-6859a, ciprofloxacin, levofloxacin, sparfloxacin, cefotaxime, imipenem, and vancomycin against nine penicillin-susceptible and -resistant pneumococci.
|
Antimicrob Agents Chemother
|
1996
|
1.90
|
|
24
|
Activities of levofloxacin, ofloxacin, and ciprofloxacin, alone and in combination with amikacin, against acinetobacters as determined by checkerboard and time-kill studies.
|
Antimicrob Agents Chemother
|
1997
|
1.87
|
|
25
|
Comparative evaluation of the API 20S system and the automicrobic system gram-positive identification card for species identification of streptococci.
|
J Clin Microbiol
|
1984
|
1.82
|
|
26
|
Susceptibilities of penicillin- and erythromycin-susceptible and -resistant pneumococci to HMR 3647 (RU 66647), a new ketolide, compared with susceptibilities to 17 other agents.
|
Antimicrob Agents Chemother
|
1998
|
1.79
|
|
27
|
Evaluation of the rapid strep system for species identification of streptococci.
|
J Clin Microbiol
|
1984
|
1.78
|
|
28
|
Susceptibility of 539 gram-positive and gram-negative anaerobes to new agents, including RP59500, biapenem, trospectomycin and piperacillin/tazobactam.
|
J Antimicrob Chemother
|
1993
|
1.76
|
|
29
|
In vitro selection of resistance to four beta-lactams and azithromycin in Streptococcus pneumoniae.
|
Antimicrob Agents Chemother
|
1998
|
1.75
|
|
30
|
Characterization of beta-lactamases from non-Bacteroides fragilis group Bacteroides spp. belonging to seven species and their role in beta-lactam resistance.
|
Antimicrob Agents Chemother
|
1990
|
1.75
|
|
31
|
Activities of gatifloxacin compared to those of seven other agents against anaerobic organisms.
|
Antimicrob Agents Chemother
|
1998
|
1.73
|
|
32
|
In vitro development of resistance to telithromycin (HMR 3647), four macrolides, clindamycin, and pristinamycin in Streptococcus pneumoniae.
|
Antimicrob Agents Chemother
|
2000
|
1.70
|
|
33
|
Susceptibility of 170 penicillin-susceptible and penicillin-resistant pneumococci to six oral cephalosporins, four quinolones, desacetylcefotaxime, Ro 23-9424 and RP 67829.
|
J Antimicrob Chemother
|
1993
|
1.69
|
|
34
|
A polyclonal outbreak of predominantly VanB vancomycin-resistant enterococci in northeast Ohio. Northeast Ohio Vancomycin-Resistant Enterococcus Surveillance Program.
|
Clin Infect Dis
|
1999
|
1.64
|
|
35
|
In vitro selection of resistance to clinafloxacin, ciprofloxacin, and trovafloxacin in Streptococcus pneumoniae.
|
Antimicrob Agents Chemother
|
2000
|
1.62
|
|
36
|
Susceptibilities of 228 penicillin- and erythromycin-susceptible and -resistant pneumococci to RU 64004, a new ketolide, compared with susceptibilities to 16 other agents.
|
Antimicrob Agents Chemother
|
1997
|
1.61
|
|
37
|
Comparative activity of ampicillin, amoxycillin, amoxycillin/clavulanate and cefotaxime against 189 penicillin-susceptible and -resistant pneumococci.
|
J Antimicrob Chemother
|
1995
|
1.58
|
|
38
|
Bacteriologic and clinical efficacy of amoxicillin/clavulanate vs. azithromycin in acute otitis media.
|
Pediatr Infect Dis J
|
2000
|
1.57
|
|
39
|
Susceptibility of penicillin-resistant pneumococci to eighteen antimicrobials: implications for treatment of meningitis.
|
J Antimicrob Chemother
|
1983
|
1.56
|
|
40
|
Evaluation of two methods for rapid testing for beta-lactamase production in Bacteroides and Fusobacterium.
|
Eur J Clin Microbiol Infect Dis
|
1990
|
1.56
|
|
41
|
Antipneumococcal activities of RP 59500 (quinupristin-dalfopristin), penicillin G, erythromycin, and sparfloxacin determined by MIC and rapid time-kill methodologies.
|
Antimicrob Agents Chemother
|
1996
|
1.51
|
|
42
|
In vitro susceptibilities of 185 penicillin-susceptible and -resistant pneumococci to WY-49605 (SUN/SY 5555), a new oral penem, compared with those to penicillin G, amoxicillin, amoxicillin-clavulanate, cefixime, cefaclor, cefpodoxime, cefuroxime, and cefdinir.
|
Antimicrob Agents Chemother
|
1994
|
1.51
|
|
43
|
Effect of CO2 on susceptibilities of anaerobes to erythromycin, azithromycin, clarithromycin, and roxithromycin.
|
Antimicrob Agents Chemother
|
1994
|
1.49
|
|
44
|
Antipneumococcal activities of gemifloxacin compared to those of nine other agents.
|
Antimicrob Agents Chemother
|
2000
|
1.49
|
|
45
|
Antipneumococcal activity of ABT-773 compared to those of 10 other agents.
|
Antimicrob Agents Chemother
|
2000
|
1.48
|
|
46
|
Characterization of a beta-lactamase from Clostridium clostridioforme.
|
J Antimicrob Chemother
|
1994
|
1.47
|
|
47
|
Structure-activity relationships of quinolone agents against mycobacteria: effect of structural modifications at the 8 position.
|
Antimicrob Agents Chemother
|
1996
|
1.46
|
|
48
|
Comparative antianaerobic activity of BMS 284756.
|
Antimicrob Agents Chemother
|
2001
|
1.44
|
|
49
|
Susceptibilities of 123 strains of Xanthomonas maltophilia to eight beta-lactams (including beta-lactam-beta-lactamase inhibitor combinations) and ciprofloxacin tested by five methods.
|
Antimicrob Agents Chemother
|
1994
|
1.44
|
|
50
|
Carriage of antibiotic-resistant pneumococci among Asian children: a multinational surveillance by the Asian Network for Surveillance of Resistant Pathogens (ANSORP).
|
Clin Infect Dis
|
2001
|
1.42
|
|
51
|
Ability of RapID Yeast Plus System to identify 304 clinically significant yeasts within 5 hours.
|
J Clin Microbiol
|
1996
|
1.41
|
|
52
|
Corynebacterium striatum: a diphtheroid with pathogenic potential.
|
Clin Infect Dis
|
1993
|
1.41
|
|
53
|
Comparative activity of trovafloxacin, alone and in combination with other agents, against gram-negative nonfermentative rods.
|
Antimicrob Agents Chemother
|
1997
|
1.37
|
|
54
|
Susceptibility of penicillin-sensitive and -resistant strains of Streptococcus pneumoniae to new antimicrobial agents, including daptomycin, teicoplanin, cefpodoxime and quinolones.
|
J Antimicrob Chemother
|
1989
|
1.37
|
|
55
|
A 1994-95 survey of Haemophilus influenzae susceptibility to ten orally administered agents. A 187 clinical laboratory center sample in the United States.
|
Diagn Microbiol Infect Dis
|
1997
|
1.37
|
|
56
|
Susceptibilities of 394 Bacteroides fragilis, non-B. fragilis group Bacteroides species, and Fusobacterium species to newer antimicrobial agents.
|
Antimicrob Agents Chemother
|
1991
|
1.35
|
|
57
|
Antipneumococcal activities of GAR-936 (a new glycylcycline) compared to those of nine other agents against penicillin-susceptible and -resistant pneumococci.
|
Antimicrob Agents Chemother
|
2000
|
1.34
|
|
58
|
Susceptibilities of non-Pseudomonas aeruginosa gram-negative nonfermentative rods to ciprofloxacin, ofloxacin, levofloxacin, D-ofloxacin, sparfloxacin, ceftazidime, piperacillin, piperacillin-tazobactam, trimethoprim-sulfamethoxazole, and imipenem.
|
Antimicrob Agents Chemother
|
1996
|
1.34
|
|
59
|
Evaluation of PCR primers to screen for Streptococcus pneumoniae isolates and beta-lactam resistance, and to detect common macrolide resistance determinants.
|
J Antimicrob Chemother
|
2001
|
1.33
|
|
60
|
Bacteriologic and clinical efficacy of high dose amoxicillin/clavulanate in children with acute otitis media.
|
Pediatr Infect Dis J
|
2001
|
1.30
|
|
61
|
Carriage of antibiotic-resistant Streptococcus pneumoniae by children in eastern and central Europe--a multicenter study with use of standardized methods.
|
Clin Infect Dis
|
1996
|
1.29
|
|
62
|
Bacteriologic efficacies of oral azithromycin and oral cefaclor in treatment of acute otitis media in infants and young children.
|
Antimicrob Agents Chemother
|
2000
|
1.28
|
|
63
|
Diagnosis of nosocomial pneumonia in intubated, intensive care unit patients.
|
Am Rev Respir Dis
|
1987
|
1.27
|
|
64
|
Activity of CP 99,219 (trovafloxacin) compared with ciprofloxacin, sparfloxacin, clinafloxacin, lomefloxacin and cefuroxime against ten penicillin-susceptible and penicillin-resistant pneumococci by time-kill methodology.
|
J Antimicrob Chemother
|
1996
|
1.27
|
|
65
|
In-vitro activity of erythromycin, roxithromycin and CP 62993 against common paediatric pathogens.
|
J Antimicrob Chemother
|
1987
|
1.26
|
|
66
|
Pneumococcal conjugate vaccine serotypes of Streptococcus pneumoniae isolates and the antimicrobial susceptibility of such isolates in children with otitis media.
|
Clin Infect Dis
|
2001
|
1.25
|
|
67
|
Activities of RPR 106972 (a new oral streptogramin), cefditoren (a new oral cephalosporin), two new oxazolidinones (U-100592 and U-100766), and other oral and parenteral agents against 203 penicillin-susceptible and -resistant pneumococci.
|
Antimicrob Agents Chemother
|
1996
|
1.24
|
|
68
|
Susceptibilities of 177 penicillin-susceptible and -resistant pneumococci to FK 037, cefpirome, cefepime, ceftriaxone, cefotaxime, ceftazidime, imipenem, biapenem, meropenem, and vancomycin.
|
Antimicrob Agents Chemother
|
1994
|
1.23
|
|
69
|
Anti-Mycobacterium avium activity of quinolones: in vitro activities.
|
Antimicrob Agents Chemother
|
1993
|
1.23
|
|
70
|
Comparative antianaerobic activities of the ketolides HMR 3647 (RU 66647) and HMR 3004 (RU 64004).
|
Antimicrob Agents Chemother
|
1997
|
1.22
|
|
71
|
Antipneumococcal activity of telithromycin by agar dilution, microdilution, E test, and disk diffusion methodologies.
|
J Clin Microbiol
|
2000
|
1.20
|
|
72
|
N-1-tert-butyl-substituted quinolones: in vitro anti-Mycobacterium avium activities and structure-activity relationship studies.
|
Antimicrob Agents Chemother
|
1996
|
1.20
|
|
73
|
Resistance patterns of streptococcus pneumoniae from carriers attending day-care centers in southwestern Greece.
|
Clin Infect Dis
|
1997
|
1.19
|
|
74
|
A bone marrow-derived murine macrophage model for evaluating efficacy of antimycobacterial drugs under relevant physiological conditions.
|
Antimicrob Agents Chemother
|
1994
|
1.19
|
|
75
|
Antipneumococcal activities of cefpirome and cefotaxime, alone and in combination with vancomycin and teicoplanin, determined by checkerboard and time-kill methods.
|
Antimicrob Agents Chemother
|
1996
|
1.18
|
|
76
|
Bacterial contamination in platelet concentrates.
|
Vox Sang
|
2014
|
1.18
|
|
77
|
Postantibiotic effect and postantibiotic sub-MIC effect of levofloxacin compared to those of ofloxacin, ciprofloxacin, erythromycin, azithromycin, and clarithromycin against 20 pneumococci.
|
Antimicrob Agents Chemother
|
1998
|
1.18
|
|
78
|
High prevalence of carriage of antibiotic-resistant Streptococcus pneumoniae in children in Kampala Uganda.
|
Int J Antimicrob Agents
|
2001
|
1.17
|
|
79
|
Bactericidal activity of DU-6859a compared to activities of three quinolones, three beta-lactams, clindamycin, and metronidazole against anaerobes as determined by time-kill methodology.
|
Antimicrob Agents Chemother
|
1997
|
1.16
|
|
80
|
Activities and postantibiotic effects of gemifloxacin compared to those of 11 other agents against Haemophilus influenzae and Moraxella catarrhalis.
|
Antimicrob Agents Chemother
|
2000
|
1.16
|
|
81
|
Comparative activities of the beta-lactamase inhibitors YTR 830, clavulanate and sulbactam combined with extended-spectrum penicillins against ticarcillin-resistant Enterobacteriaceae and pseudomonads.
|
J Antimicrob Chemother
|
1986
|
1.16
|
|
82
|
Susceptibilities of 428 gram-positive and -negative anaerobic bacteria to Bay y3118 compared with their susceptibilities to ciprofloxacin, clindamycin, metronidazole, piperacillin, piperacillin-tazobactam, and cefoxitin.
|
Antimicrob Agents Chemother
|
1993
|
1.14
|
|
83
|
Efficacy of amoxicillin/clavulanate for acute otitis media: relation to Streptococcus pneumoniae susceptibility.
|
Pediatr Infect Dis J
|
1996
|
1.13
|
|
84
|
Antianaerobic activity of the ketolide RU 64004 compared to activities of four macrolides, five beta-lactams, clindamycin, and metronidazole.
|
Antimicrob Agents Chemother
|
1997
|
1.12
|
|
85
|
MIC and time-kill studies of antipneumococcal activity of GV 118819X (sanfetrinem) compared with those of other agents.
|
Antimicrob Agents Chemother
|
1997
|
1.12
|
|
86
|
Susceptibilities of 201 anaerobes to erythromycin, azithromycin, clarithromycin, and roxithromycin by oxyrase agar dilution and E test methodologies.
|
J Clin Microbiol
|
1995
|
1.12
|
|
87
|
Pharmacokinetics, outcome of treatment, and toxic effects of amphotericin B and 5-fluorocytosine in neonates.
|
J Pediatr
|
1990
|
1.11
|
|
88
|
Susceptibilities of 123 Xanthomonas maltophilia strains to clinafloxacin, PD 131628, PD 138312, PD 140248, ciprofloxacin, and ofloxacin.
|
Antimicrob Agents Chemother
|
1994
|
1.11
|
|
89
|
Molecular characterization of multidrug-resistant Streptococcus pneumoniae isolates in Korea. The Asian Network for Surveillance of Resistant Pathogens (ANSORP) Study Group.
|
J Clin Microbiol
|
2000
|
1.10
|
|
90
|
Use of immunosuppressive agents in the treatment of severe ocular and vascular manifestations of Cogan's syndrome.
|
Am J Med
|
1990
|
1.10
|
|
91
|
Susceptibility of penicillin-susceptible and -resistant pneumococci to dirithromycin compared with susceptibilities to erythromycin, azithromycin, clarithromycin, roxithromycin, and clindamycin.
|
Antimicrob Agents Chemother
|
1997
|
1.09
|
|
92
|
Postantibiotic effect of sanfetrinem compared with those of six other agents against 12 penicillin-susceptible and -resistant pneumococci.
|
Antimicrob Agents Chemother
|
1997
|
1.09
|
|
93
|
Determination of drug susceptibility and DNA fingerprint patterns of clinical isolates of Mycobacterium tuberculosis from Kampala, Uganda.
|
East Afr Med J
|
2000
|
1.08
|
|
94
|
Antipneumococcal activity of BAY 12-8039, a new quinolone, compared with activities of three other quinolones and four oral beta-lactams.
|
Antimicrob Agents Chemother
|
1997
|
1.08
|
|
95
|
Antibiotic-resistant pneumococci.
|
Pediatr Clin North Am
|
1995
|
1.07
|
|
96
|
Bacterial clearance of biologic grafts used in hernia repair: an experimental study.
|
Surg Endosc
|
2011
|
1.07
|
|
97
|
Topical fluoroquinolones: antimicrobial activity and in vitro corneal epithelial toxicity.
|
Curr Eye Res
|
1991
|
1.07
|
|
98
|
Evaluation of RapID onE system for identification of 379 strains in the family Enterobacteriaceae and oxidase-negative, gram-negative nonfermenters.
|
J Clin Microbiol
|
1994
|
1.07
|
|
99
|
Susceptibilities of Haemophilus influenzae and Moraxella catarrhalis to ABT-773 compared to their susceptibilities to 11 other agents.
|
Antimicrob Agents Chemother
|
2001
|
1.07
|
|
100
|
Accuracy and reproducibility of the IDS rapID STR system for species identification of streptococci.
|
J Clin Microbiol
|
1986
|
1.06
|
|
101
|
Spread of multidrug-resistant Streptococcus pneumoniae in South Korea.
|
Clin Infect Dis
|
1997
|
1.05
|
|
102
|
Antimycobacterial quinolones: a comparative analysis of structure-activity and structure-cytotoxicity relationships.
|
Res Microbiol
|
1996
|
1.05
|
|
103
|
Comparative efficacies of ceftriaxone, moxalactam, and ampicillin in experimental Salmonella typhimurium infection.
|
Antimicrob Agents Chemother
|
1982
|
1.05
|
|
104
|
Anti-pneumococcal activity of gatifloxacin compared with other quinolone and non-quinolone agents.
|
J Antimicrob Chemother
|
1999
|
1.05
|
|
105
|
Time-kill study of the activity of trovafloxacin compared with ciprofloxacin, sparfloxacin, metronidazole, cefoxitin, piperacillin and piperacillin/tazobactam against six anaerobes.
|
J Antimicrob Chemother
|
1997
|
1.04
|
|
106
|
Comparative activities of clinafloxacin against gram-positive and -negative bacteria.
|
Antimicrob Agents Chemother
|
1998
|
1.03
|
|
107
|
Vitamin K-dependent carboxylation. A synthetic peptide based upon the gamma-carboxylation recognition site sequence of the prothrombin propeptide is an active substrate for the carboxylase in vitro.
|
J Biol Chem
|
1988
|
1.02
|
|
108
|
Activity of HMR 3647 compared to those of five agents against Haemophilus influenzae and moraxella catarrhalis by MIC determination and time-kill assay.
|
Antimicrob Agents Chemother
|
1998
|
1.02
|
|
109
|
Determination of activities of levofloxacin, alone and combined with gentamicin, ceftazidime, cefpirome, and meropenem, against 124 strains of Pseudomonas aeruginosa by checkerboard and time-kill methodology.
|
Antimicrob Agents Chemother
|
1998
|
1.01
|
|
110
|
Comparative activities of clarithromycin, erythromycin, and azithromycin against penicillin-susceptible and penicillin-resistant pneumococci.
|
Antimicrob Agents Chemother
|
1996
|
1.01
|
|
111
|
Activities of beta-lactams against Acinetobacter genospecies as determined by agar dilution and E-test MIC methods.
|
Antimicrob Agents Chemother
|
1997
|
1.00
|
|
112
|
Preoperative use of povidone-iodine. A prospective, randomized study.
|
Clin Orthop Relat Res
|
1986
|
0.99
|
|
113
|
Activities of three quinolones, alone and in combination with extended-spectrum cephalosporins or gentamicin, against Stenotrophomonas maltophilia.
|
Antimicrob Agents Chemother
|
1998
|
0.99
|
|
114
|
Prevalence and significance of methicillin-resistant Staphylococcus aureus in patients with cystic fibrosis.
|
Pediatr Pulmonol
|
1988
|
0.99
|
|
115
|
Establishment of the first international repository for transfusion-relevant bacteria reference strains: ISBT working party transfusion-transmitted infectious diseases (WP-TTID), subgroup on bacteria.
|
Vox Sang
|
2011
|
0.99
|
|
116
|
Comparative activities of LY 333328, a new glycopeptide, against penicillin-susceptible and -resistant pneumococci.
|
Antimicrob Agents Chemother
|
1996
|
0.98
|
|
117
|
Don't bug me: the problem of bacterial contamination of blood components--challenges and solutions.
|
Transfusion
|
2001
|
0.98
|
|
118
|
Single- and multi-step resistance selection study of gemifloxacin compared with trovafloxacin, ciprofloxacin, gatifloxacin and moxifloxacin in Streptococcus pneumoniae.
|
J Antimicrob Chemother
|
2001
|
0.98
|
|
119
|
Adhesion of Staphylococcus epidermidis to biomedical polymers: contributions of surface thermodynamics and hemodynamic shear conditions.
|
J Biomed Mater Res
|
1995
|
0.98
|
|
120
|
Anti-anaerobic activity of erythromycin, azithromycin and clarithromycin: effect of pH adjustment of media to compensate for pH shift caused by incubation in CO2.
|
J Antimicrob Chemother
|
1998
|
0.97
|
|
121
|
MIC and time-kill study of antipneumococcal activities of RPR 106972 (a new oral streptogramin), RP 59500 (quinupristin-dalfopristin), pyostacine (RP 7293), penicillin G, cefotaxime, erythromycin, and clarithromycin against 10 penicillin-susceptible and -resistant pneumococci.
|
Antimicrob Agents Chemother
|
1996
|
0.97
|
|
122
|
Use of real time pulsed field gel electrophoresis to guide interventions during a nursery outbreak of Serratia marcescens infection.
|
Pediatr Infect Dis J
|
1999
|
0.97
|
|
123
|
Anti-Mycobacterium avium activity of quinolones: structure-activity relationship studies.
|
Antimicrob Agents Chemother
|
1993
|
0.97
|
|
124
|
Susceptibility of group B streptococci to 16 beta-lactam antibiotics, including new penicillin and cephalosporin derivatives.
|
Antimicrob Agents Chemother
|
1982
|
0.96
|
|
125
|
In vitro anti-Mycobacterium avium activities of quinolones: predicted active structures and mechanistic considerations.
|
Antimicrob Agents Chemother
|
1994
|
0.96
|
|
126
|
Platelet bacterial contamination and the use of a chemiluminescence-linked universal bacterial ribosomal RNA gene probe.
|
Transfusion
|
1994
|
0.96
|
|
127
|
Penicillin-resistant pneumococcus and meningitis.
|
Ann Intern Med
|
1983
|
0.95
|
|
128
|
Activities of a new fluoroketolide, HMR 3787, and its (des)-fluor derivative RU 64399 compared to those of telithromycin, erythromycin A, azithromycin, clarithromycin, and clindamycin against macrolide-susceptible or -resistant Streptococcus pneumoniae and S. pyogenes.
|
Antimicrob Agents Chemother
|
2001
|
0.95
|
|
129
|
Evaluation of the 4-hour RapID NF Plus method for identification of 345 gram-negative nonfermentative rods.
|
J Clin Microbiol
|
1992
|
0.95
|
|
130
|
Prevalence of mefE, erm and tet(M) genes in Streptococcus pneumoniae strains from Central Italy.
|
Int J Antimicrob Agents
|
1999
|
0.95
|
|
131
|
Activity of telithromycin and seven other agents against 1034 pediatric Streptococcus pneumoniae isolates from ten central and eastern European centers.
|
Clin Microbiol Infect
|
2003
|
0.95
|
|
132
|
Comparative activity of the new fluoroquinolone Bay y3118 against 177 penicillin susceptible and resistant pneumococci.
|
Eur J Clin Microbiol Infect Dis
|
1993
|
0.94
|
|
133
|
Activities of clinafloxacin, alone and in combination with other compounds, against 45 gram-positive and -negative organisms for which clinafloxacin MICs are high.
|
Antimicrob Agents Chemother
|
1999
|
0.94
|
|
134
|
Postantibiotic effect and postantibiotic sub-MIC effect of quinupristin-dalfopristin against gram-positive and -negative organisms.
|
Antimicrob Agents Chemother
|
1998
|
0.94
|
|
135
|
Enteric fever caused by Salmonella paratyphi C in South and South West Africa.
|
S Afr Med J
|
1978
|
0.94
|
|
136
|
Treatment of active refractory rheumatoid arthritis with humanized monoclonal antibody CAMPATH-1H administered by daily subcutaneous injection.
|
Arthritis Rheum
|
1995
|
0.93
|
|
137
|
Prevalence and mechanisms of macrolide resistance in Streptococcus pyogenes in Santiago, Chile.
|
Antimicrob Agents Chemother
|
2001
|
0.92
|
|
138
|
Activity of WY-49605 compared with those of amoxicillin, amoxicillin-clavulanate, imipenem, ciprofloxacin, cefaclor, cefpodoxime, cefuroxime, clindamycin, and metronidazole against 384 anaerobic bacteria.
|
Antimicrob Agents Chemother
|
1994
|
0.92
|
|
139
|
Antipneumococcal activities of levofloxacin and clarithromycin as determined by agar dilution, microdilution, E-test, and disk diffusion methodologies.
|
J Clin Microbiol
|
1998
|
0.92
|
|
140
|
Postantibiotic effects of grepafloxacin compared to those of five other agents against 12 gram-positive and -negative bacteria.
|
Antimicrob Agents Chemother
|
2000
|
0.91
|
|
141
|
Evaluation of Etest for susceptibility testing of Mycobacterium tuberculosis.
|
J Clin Microbiol
|
2000
|
0.91
|
|
142
|
Carriage of antibiotic-resistant Streptococcus pneumoniae in Greek infants and toddlers.
|
Eur J Clin Microbiol Infect Dis
|
2000
|
0.91
|
|
143
|
Laboratory surveillance of synergy between and resistance to trimethoprim and sulfonamides.
|
Rev Infect Dis
|
1982
|
0.91
|
|
144
|
Molecular epidemiological survey of penicillin-resistant Streptococcus pneumoniae from Asia, Europe, and North America.
|
Diagn Microbiol Infect Dis
|
1999
|
0.91
|
|
145
|
Mediterranean clone of penicillin-susceptible, multidrug-resistant serotype 6B Streptococcus pneumoniae in Greece, Italy and Israel.
|
Int J Antimicrob Agents
|
2000
|
0.90
|
|
146
|
A prospective microbiologic surveillance program to detect and prevent the transfusion of bacterially contaminated platelets.
|
Transfusion
|
1994
|
0.90
|
|
147
|
Comparison of the E-test and conventional agar dilution methods for susceptibility testing of gram-negative anaerobic rods.
|
Diagn Microbiol Infect Dis
|
1994
|
0.90
|
|
148
|
Pseudomonas aeruginosa as a primary pathogen in children with bacterial peritonitis.
|
J Pediatr Surg
|
1987
|
0.90
|
|
149
|
Antibacterial activity of nitroxoline and sulphamethizole alone and in combination in urinary tract infections.
|
S Afr Med J
|
1978
|
0.90
|
|
150
|
Activity of telithromycin compared with seven other agents against 1039 Streptococcus pyogenes pediatric isolates from ten centers in central and eastern Europe.
|
Clin Microbiol Infect
|
2003
|
0.90
|
|
151
|
Lack of utility of the lysis-centrifugation blood culture method for detection of fungemia in immunocompromised cancer patients.
|
J Clin Microbiol
|
1998
|
0.89
|
|
152
|
Susceptibilities of 540 anaerobic gram-negative bacilli to amoxicillin, amoxicillin-BRL 42715, amoxicillin-clavulanate, temafloxacin, and clindamycin.
|
Antimicrob Agents Chemother
|
1992
|
0.89
|
|
153
|
Alterations of penicillin-binding proteins 1A, 2X, and 2B in Streptococcus pneumoniae isolates for which amoxicillin MICs are higher than penicillin MICs.
|
Antimicrob Agents Chemother
|
2004
|
0.88
|
|
154
|
Postantibiotic effects of gatifloxacin against gram-positive and -negative organisms.
|
Antimicrob Agents Chemother
|
1999
|
0.87
|
|
155
|
Yersinia enterocolitica biotype 1 in South Africa.
|
S Afr Med J
|
1979
|
0.86
|
|
156
|
Postantibiotic effects of garenoxacin (BMS-284756) against 12 gram-positive or -negative organisms.
|
Antimicrob Agents Chemother
|
2003
|
0.86
|
|
157
|
Postantibiotic effect of trovafloxacin against gram-positive and -negative organisms.
|
Antimicrob Agents Chemother
|
1998
|
0.86
|
|
158
|
Time-kill studies on susceptibility of nine penicillin-susceptible and -resistant pneumococci to cefditoren compared with nine other beta-lactams.
|
J Antimicrob Chemother
|
1997
|
0.86
|
|
159
|
Escherichia coli gastro-enteritis in adults.
|
S Afr Med J
|
1978
|
0.86
|
|
160
|
Anti-anaerobic activity of levofloxacin alone and combined with clindamycin and metronidazole.
|
Diagn Microbiol Infect Dis
|
2000
|
0.86
|
|
161
|
Serratia marcescens strains implicated in adverse transfusion reactions form biofilms in platelet concentrates and demonstrate reduced detection by automated culture.
|
Vox Sang
|
2011
|
0.86
|
|
162
|
Susceptibilities of 200 penicillin-susceptible and -resistant pneumococci to piperacillin, piperacillin-tazobactam, ticarcillin, ticarcillin-clavulanate, ampicillin, ampicillin-sulbactam, ceftazidime, and ceftriaxone.
|
Antimicrob Agents Chemother
|
1994
|
0.85
|
|
163
|
Efficacy and safety of sequential treatment with parenteral sulbactam/ampicillin and oral sultamicillin for skeletal infections in children.
|
Rev Infect Dis
|
1987
|
0.85
|
|
164
|
Genetic analysis of serotype 23F Streptococcus pneumoniae isolates from several countries by penicillin-binding protein gene fingerprinting and pulsed-field gel electrophoresis.
|
Chemotherapy
|
1999
|
0.84
|
|
165
|
Epidemic listeriosis. Report of 14 cases detected in 9 months.
|
S Afr Med J
|
1978
|
0.84
|
|
166
|
Antipneumococcal activity of grepafloxacin compared to that of other agents by time-kill methodology.
|
Antimicrob Agents Chemother
|
1998
|
0.83
|
|
167
|
Activity of telithromycin (HMR 3647) against anaerobic bacteria compared to those of eight other agents by time-kill methodology.
|
Antimicrob Agents Chemother
|
1999
|
0.83
|
|
168
|
Streptococcus mitis. A cause of serious infection in adults.
|
Arch Intern Med
|
1987
|
0.83
|
|
169
|
Resistance patterns of Streptococcus pneumoniae from children in central Italy.
|
Eur J Clin Microbiol Infect Dis
|
1999
|
0.83
|
|
170
|
Antimicrobial activity of B-Lock against bacterial and Candida spp. causing catheter-related bloodstream infections.
|
Antimicrob Agents Chemother
|
2011
|
0.83
|
|
171
|
Chromobacterium violaceum adenitis acquired in the northern United States as a complication of chronic granulomatous disease.
|
Pediatr Infect Dis
|
1986
|
0.83
|
|
172
|
Alternaria infection in a patient with acquired immunodeficiency syndrome: case report and review of invasive alternaria infections.
|
Rev Infect Dis
|
1988
|
0.83
|
|
173
|
Multiple-antibiotic resistance--now the pneumococcus.
|
J Antimicrob Chemother
|
1978
|
0.82
|
|
174
|
Postantibiotic effects of daptomycin against 14 staphylococcal and pneumococcal clinical isolates.
|
Antimicrob Agents Chemother
|
2003
|
0.82
|
|
175
|
Antimicrobial activity and in vitro corneal epithelial toxicity of antimicrobial agents for gram-positive corneal pathogens.
|
Curr Eye Res
|
1993
|
0.81
|
|
176
|
Aspergillosis due to carpet contamination.
|
Infect Control Hosp Epidemiol
|
1994
|
0.81
|
|
177
|
Comparison of agar dilution, microdilution, Etest and disc diffusion to test the activity of trovafloxacin against Pseudomonas aeruginosa, methicillin-resistant Staphylococcus aureus and Streptococcus pneumoniae.
|
J Antimicrob Chemother
|
1999
|
0.81
|
|
178
|
Comparison of agar dilution, microdilution, E-test, and disk diffusion methods for testing activity of cefditoren against Streptococcus pneumoniae.
|
J Clin Microbiol
|
1999
|
0.81
|
|
179
|
In vitro activities of cefminox against anaerobic bacteria compared with those of nine other compounds.
|
Antimicrob Agents Chemother
|
1998
|
0.81
|
|
180
|
Antimicrobial resistance of Streptococcus pneumoniae and Haemophilus influenzae in Sao Paulo, Brazil from 1996 to 2000.
|
Int J Antimicrob Agents
|
2004
|
0.80
|
|
181
|
Synergic activity, for anaerobes, of trovafloxacin with clindamycin or metronidazole: chequerboard and time-kill methods.
|
J Antimicrob Chemother
|
2000
|
0.80
|
|
182
|
Clinically significant concentrations of local anesthetics inhibit Staphylococcus aureus in vitro.
|
Int J Obstet Anesth
|
2002
|
0.80
|
|
183
|
Synergistic activity of trovafloxacin with other agents against gram-positive and -negative organisms.
|
Diagn Microbiol Infect Dis
|
1998
|
0.79
|
|
184
|
Activity of HMR 3647 compared to those of six compounds against 235 strains of Enterococcus faecalis.
|
Antimicrob Agents Chemother
|
1999
|
0.79
|
|
185
|
Activities and time-kill studies of selected penicillins, beta-lactamase inhibitor combinations, and glycopeptides against Enterococcus faecalis.
|
Antimicrob Agents Chemother
|
1998
|
0.79
|
|
186
|
Diagnosis and treatment of upper respiratory tract infections in the primary care setting.
|
Clin Ther
|
2001
|
0.79
|
|
187
|
Penicillin susceptibility testing of gonococci by disc diffusion.
|
J Antimicrob Chemother
|
1981
|
0.79
|
|
188
|
Susceptibility of twenty penicillin-susceptible and -resistant pneumococci to levofloxacin, ciprofloxacin, ofloxacin, erythromycin, azithromycin, and clarithromycin by MIC and time-kill.
|
Diagn Microbiol Infect Dis
|
1997
|
0.79
|
|
189
|
Emergence of antibiotic resistance in upper and lower respiratory tract infections.
|
Am J Manag Care
|
1999
|
0.78
|
|
190
|
Comparison of the activity of fluoroquinolones against Mycobacterium avium in cell-free systems and a human monocyte in-vitro infection model.
|
J Antimicrob Chemother
|
1996
|
0.78
|
|
191
|
Single- and multistep selection study of the antipneumococcal activity of BMS-284756 compared to ciprofloxacin, levofloxacin, trovafloxacin and moxifloxacin.
|
Clin Microbiol Infect
|
2002
|
0.78
|
|
192
|
Evaluation of the Micro-ID, the API 20E and the Rapid 20E for same-day identification of Enterobacteriaceae.
|
Eur J Clin Microbiol
|
1985
|
0.78
|
|
193
|
Bacterial contamination of platelets at a university hospital: increased identification due to intensified surveillance.
|
Infect Control Hosp Epidemiol
|
1994
|
0.78
|
|
194
|
Prevalence and characteristics of pharyngeal group A beta-hemolytic streptococci in US Navy recruits receiving benzathine penicillin prophylaxis.
|
J Infect Dis
|
1992
|
0.78
|
|
195
|
In vitro development of resistance to ceftriaxone, cefprozil and azithromycin in Streptococcus pneumoniae.
|
J Antimicrob Chemother
|
2000
|
0.78
|
|
196
|
Release of complement regulatory proteins from ocular surface cells in infections.
|
Curr Eye Res
|
2000
|
0.78
|
|
197
|
Synergy of amoxycillin combined with clavulanate and YTR 830 in experimental infections in mice.
|
J Antimicrob Chemother
|
1986
|
0.77
|
|
198
|
Activities of oral and parenteral agents against penicillin-susceptible and -resistant pneumococci.
|
Antimicrob Agents Chemother
|
1995
|
0.77
|
|
199
|
Prevalence of Toxoplasma antibodies in Southern Africa.
|
S Afr Med J
|
1978
|
0.76
|
|
200
|
Postmortem diagnosis of meningococcemia by detection of capsular polysaccharides.
|
J Forensic Sci
|
1988
|
0.76
|
|
201
|
Characterization of penicillin intermediate serotypes of Streptococcus pneumoniae carried by human immunodeficiency virus-infected adults and healthy children in Uganda.
|
Microb Drug Resist
|
2007
|
0.76
|
|
202
|
Macrolide resistance phenotypes in Streptococcus pneumoniae in Santiago, Chile.
|
Int J Antimicrob Agents
|
2002
|
0.76
|
|
203
|
A phase II/III trial of antimicrobial therapy with or without amikacin in the treatment of disseminated Mycobacterium avium infection in HIV-infected individuals. AIDS Clinical Trials Group Protocol 135 Study Team.
|
AIDS
|
1998
|
0.76
|
|
204
|
Methicillin-resistant Staphylococcus aureus sepsis associated with the transfusion of contaminated platelets: a case report.
|
Transfusion
|
2001
|
0.76
|
|
205
|
Diagnostic microbiology and therapeutic drug monitoring in pediatric infectious diseases.
|
Pediatr Clin North Am
|
1983
|
0.76
|
|
206
|
Fulminant endocarditis and disseminated infection caused by carbapenem-resistant Acinetobacter baumannii in a renal-pancreas transplant recipient.
|
Transpl Infect Dis
|
2015
|
0.75
|
|
207
|
Disseminated Bacillus Calmette-Guérin (BCG) infection following allogeneic hematopoietic stem cell transplant in a patient with Bare Lymphocyte Syndrome type II.
|
Transpl Infect Dis
|
2014
|
0.75
|
|
208
|
Treatment of experimental Salmonella typhimurium infection in mice with fleroxacin.
|
Antimicrob Agents Chemother
|
1988
|
0.75
|
|
209
|
A poison information service for small animals offered by a regional poison center.
|
Vet Hum Toxicol
|
1991
|
0.75
|
|
210
|
Activity of trovafloxacin, alone and in combination with other agents, against Enterobacteriaceae by time-kill analysis.
|
Eur J Clin Microbiol Infect Dis
|
2000
|
0.75
|
|
211
|
Health care research in rheumatology.
|
Curr Opin Rheumatol
|
1993
|
0.75
|
|
212
|
Activity of gemifloxacin, a new broad-spectrum quinolone, against 200 pneumococci by four different susceptibility testing methods.
|
J Antimicrob Chemother
|
2000
|
0.75
|
|
213
|
Activity of new quinolones against intracellular Mycobacterium avium in human monocytes.
|
J Antimicrob Chemother
|
1997
|
0.75
|
|
214
|
Resistant pneumococcal infections.
|
Compr Ther
|
1979
|
0.75
|
|
215
|
Pharmacists' attitudes and knowledge related to their role in osteoporosis education.
|
Am Pharm
|
1988
|
0.75
|
|
216
|
Serological survey of toxoplasmosis in the Transvaal.
|
S Afr Med J
|
1974
|
0.75
|
|
217
|
The immune response in iron-deficient children. Isohaemagglutinin titres and antibody response to immunization.
|
S Afr Med J
|
1978
|
0.75
|
|
218
|
The incidence of penicillin-resistant pneumococci in the Slovak Republic. Pneumococcus Study Group.
|
Chemotherapy
|
1997
|
0.75
|
|
219
|
Serotypes and antimicrobial susceptibility in clinical isolates of Haemophilus influenzae from Korean children in prevaccination era.
|
J Korean Med Sci
|
2000
|
0.75
|
|
220
|
Group B streptococcal infections in neonates and infants. Report of 16 cases, with referrence to the fatal outcome in late-onset leucopenic cases.
|
S Afr Med J
|
1978
|
0.75
|
|
221
|
Botulism: a case report.
|
S Afr Med J
|
1980
|
0.75
|
|
222
|
Centralized, pharmacist-managed anticoagulation service for a university-based health system.
|
Am J Health Syst Pharm
|
2001
|
0.75
|
|
223
|
In vitro susceptibility of pneumococci to trovafloxacin, penicillin G, and other antimicrobial agents in the Czech Republic and Slovakia.
|
Eur J Clin Microbiol Infect Dis
|
1996
|
0.75
|
|
224
|
Activity of the new quinolone WCK 771 against pneumococci.
|
Clin Microbiol Infect
|
2005
|
0.75
|
|
225
|
Cefditoren in vitro activity and spectrum: a review of international studies using reference methods.
|
Diagn Microbiol Infect Dis
|
2001
|
0.75
|
|
226
|
Cefoperazone/sulbactam versus cefoperazone plus mezlocillin: empiric therapy for febrile, neutropenic bone marrow transplant patients.
|
Int J Antimicrob Agents
|
1996
|
0.75
|
|
227
|
Antipneumococcal activity of MEN 10700, a new penem, compared with other compounds, by MIC and time-kill kinetics.
|
J Antimicrob Chemother
|
1999
|
0.75
|
|
228
|
Activity of DU-6859a, ciprofloxacin, ofloxacin, levofloxacin, sparfloxacin and OPC-17116 against 112 penicillin-susceptible and -resistant pneumococci.
|
Drugs
|
1995
|
0.75
|
|
229
|
In vitro anti-anaerobic activity of the cephalosporin derivative RWJ 54428, compared to seven other compounds.
|
Clin Microbiol Infect
|
2002
|
0.75
|
|
230
|
Specific detection of Mycobacterium tuberculosis in radiometric cultures by using an immunoassay for antigen 5.
|
J Infect Dis
|
1988
|
0.75
|
|
231
|
The value of radiation therapy in uterine sarcoma.
|
Obstet Gynecol
|
1975
|
0.75
|
|
232
|
Absence of antibiotic-resistant Streptococcus pneumoniae pharyngeal colonization in Cleveland children with sickle cell disease.
|
Pediatr Infect Dis J
|
1993
|
0.75
|